Current Hematologic Malignancy Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of conditions associated with hematologic malignancy.

  • Offers the views of experts on current advances in the field of hematologic malignancy
  • Gathers and highlights important recent papers from a wealth of original publications
  • Draws on the expertise of authorities in 12 related subject areas

Journal information

Editor-in-Chief
  • Ruben A. Mesa
Publishing model
Hybrid. Open Access options available

Journal metrics

2.397 (2018)
Impact factor
2.089 (2018)
Five year impact factor
72,770 (2018)
Downloads

Latest articles

This journal has 33 open access articles

Subscribe

  • Immediate online access
  • Full Journal access includes all articles
  • Downloadable in PDF
  • Subscription expires 12/31/2020

Advertisement

About this journal

Electronic ISSN
1558-822X
Print ISSN
1558-8211
Abstracted and indexed in
  1. CNKI
  2. Current Contents/Clinical Medicine
  3. EBSCO Biomedical Reference Collection
  4. EBSCO Discovery Service
  5. EMBASE
  6. Gale
  7. Gale Academic OneFile
  8. Google Scholar
  9. Institute of Scientific and Technical Information of China
  10. Japanese Science and Technology Agency (JST)
  11. Journal Citation Reports/Science Edition
  12. Medline
  13. Naver
  14. OCLC WorldCat Discovery Service
  15. ProQuest-ExLibris Primo
  16. ProQuest-ExLibris Summon
  17. Reaxys
  18. SCImago
  19. SCOPUS
  20. Science Citation Index Expanded (SciSearch)
  21. Semantic Scholar
Copyright information

Rights and permissions

Springer policies

© Springer Science+Business Media, LLC, part of Springer Nature